PeptiMimesis Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $1.45M
Latest Deal Amount
  • Investors
  • 2

PeptiMimesis General Information

Description

Developer of transmembrane therapeutic peptides designed to identify peptidomimetic candidates suffering from hetero. The company's platform offers transmembrane therapeutic peptides having key competitive advantages over antibodies such as a improved drug discovery process and reduced manufacturing cost, enabling patients to buy medicines at comparatively low cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 850 Boulevard Sébastien Brant
  • Bioparc
  • 67400 Illkirch
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PeptiMimesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 15-Mar-2017 $1.45M 00.000 00.000 Completed Generating Revenue
To view PeptiMimesis’s complete valuation and funding history, request access »

PeptiMimesis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.0 000.0 000.0 0.000
A 0,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 17,000 $1.059897
To view PeptiMimesis’s complete cap table history, request access »

PeptiMimesis Executive Team (5)

Name Title Board Seat Contact Info
Marjorie Sidhoum Ph.D President
Gerard Cremel Co-Founder & Founding Member
Dominique Bagnard Ph.D Co-Founder
Pascal Neuville Co-Founder
Pierre Hubert Co-Founder
To view PeptiMimesis’s complete executive team members history, request access »

PeptiMimesis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capital Grand Est PE/Buyout Minority 000 0000 000000 0
Domain Therapeutics VC-Backed Company Minority 000 0000 000000 0
To view PeptiMimesis’s complete investors history, request access »

PeptiMimesis Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000000000 08-Jun-2020 00000 00000 00 Drug Discovery 00000000 0000000 00.0
To view PeptiMimesis’s complete investments history, request access »